La E, Poston S, Curran D, Lorenc S, Salem AE, Carrico J, Hicks KA, Anderson S, Carpenter CF. Cost-effectiveness analysis of recombinant zoster vaccine for vaccinating immunocompromised adults against Herpes Zoster in the United States. Presented at the ACIP Herpes Zoster Working Group; April 2021. Atlanta, GA.


Abstract not available at this time.

Share on: